Annovis Bio's total assets for Q1 2026 were $16.24M, a decrease of -22.95% from the previous quarter. ANVS total liabilities were $13.12M for the fiscal quarter, a 210.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.